The massive market transformation this month that some on Wall Street called a "once in a decade opportunity" might have just been a one-off technical move because of taxes.Marketsread more
The Pentagon will deploy U.S. forces to the Middle East on the heels of the attack on Saudi Arabian oil facilities, United States Secretary of Defense Mark Esper announced...Defenseread more
Iran's audacious drone and cruise missile attack on Saudi Arabia's oil producing facilities has provided a critical test yet for the Trump administration's foreign policy. A...Politicsread more
Shares of MasterCard are up 46% this year, and 1120% since 2011, getting a boost from the strong U.S. consumer.Investingread more
Chinese trade negotiators suddenly canceled a visit to meet U.S. farmers after they wrapped up trade talks in Washington this week.Marketsread more
Blackstone Executive Vice Chairman Tony James says he's less optimistic now than before that the U.S.-China trade war could be resolved, but even a smaller deal could help...World Economyread more
Progress on trade talks will determine how far market will move above new highs.Trader Talk with Bob Pisaniread more
"Sure, the trade war's taking its toll on business ... it's just not taking its toll where it was supposed to," Jim Cramer says.Mad Money with Jim Cramerread more
Joe Biden called on President Donald Trump Friday to release the transcript of a call with a foreign leader that is the subject of a whistleblower complaint. Biden described...Politicsread more
President Trump also said he is "not looking for a partial deal" with Beijing, moving away from his suggestion last week that he would consider an "interim deal."Politicsread more
Aurora Cannabis Executive Chairman Michael Singer said Thursday that he is concerned about the uncertain situation around vaping in the United States.
Singer's comments on CNBC's "Power Lunch" come one day after the Trump administration announced it was preparing to ban flavored e-cigarettes, as federal health officials seek to combat an outbreak of a mysterious yet deadly lung disease. It has sickened hundreds and killed at least six people.
"Personally, I am very worried about what I'm reading in the U.S.," said Singer, whose cannabis company is based in Alberta, Canada. "In Canada, it's very different, and we're heavily regulated by Health Canada, which is a good thing."
Aurora is one of the world's largest cannabis producers.
The Trump administration's plans call for all non-tobacco-flavored products to be removed from the market within 30 days. Companies may be able to sell them later on, but that will require approval from the Food and Drug Administration.
E-cigarettes are a relatively new market, and the FDA was going to begin reviewing them last summer, but former FDA Commissioner Scott Gottlieb delayed that process until 2022. The proposal outlined Wednesday essentially moves the FDA's timeline to review flavors up to this year. The increasing use of vaping products by children has caused worry among health officials.
While the Trump administration's planned crackdown deals with flavored tobacco, there are also cannabis vaping products. The Washington Post reported last week that health officials investigating the lung disease outbreak have found the same substance in some cannabis products that was in products used by people who fell ill.
A spokeswoman for the National Cannabis Industry Association told Marijuana Business Daily that the proposed e-cigarette restrictions have caused "preliminary concern" that it could later impact how marijuana is regulated in the U.S., if it becomes legal.
Singer said Aurora, which has seen its stock drop 8.5% Thursday after it posted weak earnings guidance and a large fourth quarter revenue miss, works closely with Health Canada in order to meet safety standards in the country.
"When it comes to vaping or vaping products that we're going to be launching, we're going to be testing every one of our products to a rigorous standard to ensure the products we offer to consumers are safe and we feel comfortable that we are not in any way putting at risk our customers or our patients with regards to our derivative products," Singer said.
— CNBC's Angelica LaVito contributed to this report.